Amgen Stock Soars as Biotech Company Shows Promise in Obesity Study
**Unlocking the Potential of Amgen: A Closer Look at the Promising MariTide Obesity Treatment** Amgen (AMGN) investors have reason to celebrate as the biotech giant recently shared its interim results of the MariTide obesity treatment, … Read more